Viazen Immunity: The selenium content is out of specification in the affected batch.
Brand(s)
Last updated
Summary
Product
Viazen Immunity
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Viazen Immunity | Viazen Immunity | NPN 80104797 | Capsules | Astragalus membranaceus (140.0 mg), Camellia sinensis (50.0 mg), Ganoderma lucidum (140.0 mg), Selenium (75.0 mcg), Vaccinium angustifolium (25.0 mg), Zinc (25.0 mg) | 242811IMN |
Issue
The (selenium) content is out of specification in the affected batch.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Distripharm Inc.
1440-100 Hocquart,
St-Bruno, QC,
J3V 6E1
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-81377
Get notified
Receive emails about new and updated recall and safety alerts.